Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Ranibizumab treatment for neovascular age-related macular degeneration in patients with good baseline visual acuity (better than 6/12): 12-month outcomes.

× No keyword cloud information.

5 in total

1. Outcome of ranibizumab treatment in neovascular age related macula degeneration in eyes with baseline visual acuity better than 6/12.

Authors: T A Williams; C P Blyth
Journal: Eye (Lond) Date: 2011-09-16 Impact factor: 3.775

2. Effectiveness of ranibizumab intravitreal injections for exudative age-related macular degeneration treatment: 12-month outcomes.

Authors: Figurska Małgorzata; Andrzej Stankiewicz
Journal: Med Sci Monit Date: 2011-09

3. Factors predicting 2-year treatment results of ranibizumab therapy for polypoidal choroidal vasculopathy in eyes with good baseline visual acuity.

Authors: Ryusaburo Mori; Koji Tanaka; Mitsuko Yuzawa
Journal: Medicine (Baltimore) Date: 2018-06 Impact factor: 1.889

4. Five-year outcomes of intravitreal drug therapy for neovascular age-related macular degeneration in eyes with baseline vision 20/60 or better.

Authors: Arshad M Khanani; Greggory M Gahn; Micaela M Koci; Jonathan M Dang; Sandra M Brown; Lauren F Hill
Journal: Clin Ophthalmol Date: 2019-02-13

Review 5. Managing Neovascular Age-Related Macular Degeneration in Clinical Practice: Systematic Review, Meta-Analysis, and Meta-Regression.

Authors: Daniele Veritti; Valentina Sarao; Valentina Soppelsa; Carla Danese; Jay Chhablani; Paolo Lanzetta
Journal: J Clin Med Date: 2022-01-10 Impact factor: 4.241

5 in total